Methyl CCNU and adriamycin for patients with metastatic sarcomas a southwest oncology group study
โ Scribed by Saul E. Rivkin; Jeffrey A. Gottlieb; Tate Thigpen; Nazli Gad El Mawla; John Saiki; Dennis O. Dixon
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 401 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1 , plus 5-FU day 1 and 8 , and cyclophosphamide day 1 (AFC), and adriamycin day 1 plus 5-FU day 1 and 8 , c
Background. The objectives of this study were to compare vincristine/actinomycin D/cyclophosphamide/adriamycin (VACA) with VACA plus imidazole carboxamide (DTIC) (VACAD) therapy in regards to complete/partial response and event free survival rates in children and adolescents with metastatic non-rhab